1 
行政院國家科學委員會專題研究計畫成果報告 
慢性病程模型最佳化-以 B 型肝炎為例 
Optimal Modeling of Chronic Disease Dynamics — with Examples on Chronic 
Hepatitis B Virus Infection 
 
計 畫 編 號：NSC 98-2218-E-004-002 
執 行 期 限：98年 10月 01日至 99年 10月 31日 
主 持 人：陳政輝 政治大學應用數學系 
計畫參與人員：陳盈穎、 陳玫芳 政治大學應用數學系 
 
一、中文摘要 
慢性病的病程研究具有基本的重要性，因為藉由這些研究，研究人員可以更了解病程發
展的機制，進而發展出更有效的治療方法，改善患者的病況或延長其壽命。根據統計，臺灣
地區的慢性B型肝炎約有超過三百萬的帶原者。隨著病程進展，將來可能發展為肝硬化或肝
癌，不但嚴重影響國人健康，也造成健保的沉重負擔。因此，藉由研究慢性B型肝炎自然病
程，提供病患相關資訊及醫療專家精確病程模型，對衛生保健、醫學研究及健保給付評估為
相當重要之工作。 
 
 文獻中，有許多由醫學觀點建立之病程模型。然而，在許多應用中，由於模型簡化如未
適當考慮年齡因素，結果將造成相當大的誤差。本研究考慮生命年表，將模型適切修正，使
模型能更貼近真實狀況，並進行嚴格數學分析。所發展之數值工具，可估算在一定年限下，
病程發展至特定狀態之機率，達到提供病患相關資訊，有助其後續醫療選擇及保健。 
關鍵詞：馬可夫模型, 慢性 B 型肝炎, 存活分析 
 
Abstract 
The progression of chronic diseases plays an important role on their research. Through related 
studies, researchers can frequently extract information to design better clinic protocols to extend or 
improve patients’ lives. According to statistics, there are more than 3 million carriers of hepatitis B 
virus infection in Taiwan. Its adverse sequelae could be liver cirrhosis or hepatocellular carcinoma 
(HCC). This greatly threatens people’s lives and also leads to significant burden to national health 
insurance. Therefore, the study on progression of chronic HBV infection is of fundamental 
importance to Taiwanese society. 
 
 In the literature, several disease progression models on HBV have been proposed. However, 
due to over-simplification such as non -age-dependence, these models can lead to significant errors 
3 
 
 
Figure 1. A model on HBV infection from Liaw and Chu [1]
 
To correct these disadvantages of the original model, we improve it with the following two 
steps. First, based on the understanding to HBV progression, the model is transformed into a valid 
Markov model. Secondly, data from life table is incorporated into this model to provide adjustments 
and offers a more realistic approximation to disease progression on HBV [5][6]. 
 
To facilitate our presentation on how data in life table is incorporated into the model, we 
illustrate by focusing on one specific transition in Figure 1 (i.e. state “HBeAg(+) hepatitis and 
HBV-DNA> 4 52 10×   IU/mL” to state “Liver cirrhosis.”) Such a transition is only possible under 
the condition that the patient survives up to the following year. Therefore, data from life table can 
be embedded based on conditional probability. For instance, suppose that one 18-year-old patient is 
with the state “HBeAg(+) hepatitis and HBV-DNA> 4 52 10×   IU/mL.” Denote 18p  the probability 
in life table that a 18-year-old person will survive up to the following year. Transitions from this 
initial state and age in Figure 1 and their associated probabilities can be summarized as follows. 
 
(1) With probability 181 p− , the patient will die in the following year. 
(2) With probability 180.04 ,p  the next state of this patient will be “Liver cirrhosis.” 
(3) With probability 180.005 ,p  the next state will be “Decomposition.”  
(4) With probability 180.008 ,p  the next state will be “HCC.” 
(5) With probability (1-0.04-0.005-0.08) 18 ,p  the next state will be the original state. 
These transitions are summarized as Figure 2. 
5 
following conclusions: 2L  is finite and 12 LL ≤ . We also provide exact mathematical formulae of 
the upper and lower bounds on 1L - 2L . From our study, it shows that when the death rate varies 
significantly with age, the variation between these two models will increase accordingly. The 
detailed results may be referred to our subsequently submitted papers [7]. 
 
3.5 Applications 
 
 The developed model and tools can be applied to study several related applications. For 
instance, it can be used to compute the probability that a patient arrives one specific health status 
from a given initial age and initial health state. The following examples demonstrate how our 
numerical procedures can provide such information. 
 
Example 1:[5][6]  
 
Suppose that a patient is infected with HBV at aged 25. Our developed tool provides the 
information of that he or she will undergo disease progression to critical medical events when he or 
she is at age 40. The result is summarized in the Table 1. 
 
In Table 1, each probability on the right column indicates the possibility that the patient will 
reach the corresponding events shown on the left column at aged 40. 
 
Critical medical events Probability 
Seroconversion & 
Sustained Remission 
25% 
Decompensation 4% 
Liver cirrhosis 16% 
HBsAg loss 3% 
HCC 7% 
Death/Transplantation 37% 
Table 1.  Probabilities of critical events. 
 
Example 2.[5][6]  
 
A patient at aged 40 is diagnosed as “liver cirrhosis.” The probabilities that he or she will reach 
the listed health states at the age of 60 are summarized in Table. 2 
 
 
 
 
 
7 
[4]  S. I. Resnick, Adventures in Stochastic Processes, Birkhauser, Boston, 1994. 
[5]  S. Y. Chen, P. H. Luh, J. H. Chen and R. N. Chien, “An Age-Dependent Model with Survival 
Analysis on Chronic Hepatitis B Virus Infection,” in preparation.  
[6]  陳欣毓,慢性 B 型肝炎病毒感染之年齡相關模型及存活機率分析, 政治大學應用數學研
究所碩士論文,2010. 
[7]  J. H. Chen and P. H. Luh,” Analysis on Life Table Embedded Model,” in preparation.
 
98年度專題研究計畫研究成果彙整表 
計畫主持人：陳政輝 計畫編號：98-2218-E-004-002- 
計畫名稱：慢性病程模型最佳化-以 B型肝炎為例 
量化 
成果項目 實際已達成
數（被接受
或已發表）
預期總達成
數(含實際已
達成數) 
本計畫實
際貢獻百
分比 
單位 
備 註 （ 質 化 說
明：如數個計畫
共同成果、成果
列 為 該 期 刊 之
封 面 故 事 ...
等） 
期刊論文 0 0 0%  
研究報告/技術報告 1 1 100% 
本計畫結果, 已
被用於撰寫一碩
士論文 
研討會論文 1 0 0% 
篇 
 
論文著作 
專書 0 0 0%   
申請中件數 0 0 0%  專利 已獲得件數 0 0 0% 件  
件數 0 0 0% 件  
技術移轉 
權利金 0 0 0% 千元  
碩士生 2 2 100%  
博士生 0 0 0%  
博士後研究員 0 0 0%  
國內 
參與計畫人力 
（本國籍） 
專任助理 0 0 0% 
人次 
 
期刊論文 0 0 0% 
根據本計畫研究
成果, 撰寫兩篇
期刊論文. 第一
篇已完成,將於修
改後投稿至期刊. 
第二篇已完成部
份初稿, 目前仍
撰寫中, 論文題
目與部份細節可
參考成果報告. 
研究報告/技術報告 0 0 0%  
研討會論文 0 0 0% 
篇 
 
論文著作 
專書 1 0 0% 章/本  
申請中件數 0 0 0%  專利 已獲得件數 0 0 0% 件  
件數 0 0 0% 件  
技術移轉 
權利金 0 0 0% 千元  
碩士生 0 0 0%  
博士生 0 0 0%  
國外 
參與計畫人力 
（外國籍） 
博士後研究員 0 0 0% 
人次 
 
 
